Home | TS Index | Previous | Next | Causes/Risk Factors | Therapy | Updates

 

Uncomplicated/CA UTI | Complicated & Pyelonephritis | Complicated Catheterized/ Institutional | Uro-sepsis | Candidal UTI | Prostatitis | Prevention and treatment w/ Cranberry juice, Vit C, and Pyridium | Flow Chart |

 

Complicated & Pyelonephritis

§   Not all patients with complicated UTI’s will have resistant isolates.  Many patients in the community with complicated UTI’s start off with community acquired/susceptible isolates that become resistant with time

§   Outpatient complicated therapy is generally the same as uncomplicated except the higher end of dosing is generally used and therapy is for 7-10 days

§    Most frequently used, higher dose TMP/SMX DS or Quinolones x 7-10 days

 

Complicated catheterized and institutional patients

MRSA/MRSE Vancomycin IV x 10-14 days
Enterococcus faecalis Ampicillin IV 1-2 g q6-8h +/- Vancomycin (if VRE as in case of uro-sepsis)
Gram negatives Ciprofloxacin 500-750 mg PO q12h or 400 mg IV q12h

Levofloxacin 500 mg IV q24h

Ceph II or Ceph III

Gentamicin/Tobramicin 1.5 mg/kg q8-12h (peak 5-6 mcg/ml)

Piperacillin 2-4 g q8h or zillacillin if beta-lactamase present

Pseudomonas aeruginosa Ciprofloxacin

Cetfazidime 1 g IV q8h

Cefepime 1 g IV q12h

Aztreonam 1 g IV q8h

Gentamicin/Tobramicin if resistant as in case of uro-sepsis

 

Uro-sepsis

Caused by E. faecalis, VRE, enterobacteriaceae, P. aeruginosa...

E. faecalis Ampicillin +/- Gentamicin

Vancomycin +/- Gentamicin

Linezolid 600 mg IV q12h

E. faecium Same

If VRE, use Linezolid and Synercid

E. coli Pen, Cephs, Quinolones (see above)
Enterobacteriaceae Aminoglycoside/Cipro plus one of below

      Cetfazidime/Cefepime/Aztreonam

      Piperacillin/Mezlocillin

      Imipenem cilastatin

P. aeruginosa Same as Enterobacteriaceae

 

Uncomplicated/CA UTI | Complicated & Pyelonephritis | Complicated Catheterized/ Institutional | Uro-sepsis | Candidal UTI | Prostatitis | Prevention and treatment w/ Cranberry juice, Vit C, and Pyridium | Flow Chart |

 

Home | TS Index | Previous | Next | Causes/Risk Factors | Therapy | Updates